---  
layout: startup_page  
title: "Nuevocor"  
id: "nuevocor.com"  
permalink: "/nuevocornuevocor.com05062025/"  
website: "https://www.nuevocor.com/"  
funding_round: "Series B"  
funding_amount: "$45M"  
investors: "Kurma Partners, Angelini Ventures, EDBI, ClavystBio, Boehringer Ingelheim Venture Fund, Highlight Capital, SEEDS Capital"  
about: "Nuevocor is an IND-stage biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology. Their proprietary PrOSIATM platform aims to address the root cause of disease across multiple cardiomyopathies, specifically focusing on LMNA-related dilated cardiomyopathy (LMNA DCM). The company's lead candidate, NVC-001, is a first-in-class, AAV-based gene therapy currently in Phase 1/2 clinical trials."  
markets: "Biotech, Gene Therapy, Healthcare"  
hq: "Singapore, Singapore"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/nuevocor"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/nuevocor"  
pitchbook: "https://pitchbook.com/profiles/company/468003-43"  

date_display: "06-May-2025"  
date: "2025-05-06"

# SEO Optimization  
meta_title: "Nuevocor - Series B Funding ($45M)"  
meta_description: "Nuevocor, Nuevocor is an IND-stage biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology. Their propri..."  
meta_keywords: "Nuevocor, Biotech, Gene Therapy, Healthcare, Series B funding"  
canonical_url: "https://startup.projectstartups.com/nuevocornuevocor.com05062025/"  
---